Publications
2011
KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib.
Gleixner KV,
Mayerhofer M,
Cerny-Reiterer S,
Hormann G,
Rix U,
Bennett KL,
Hadzijusufovic E,
Meyer RA,
Pickl WF,
Gotlib J,
Horny HP,
Reiter A,
Mitterbauer-Hohendanner G,
Superti-Furga G,
Valent P.
Blood. 2011 Aug 18;118(7):1885-98.
2010
CD14 is a co-receptor of Toll-like receptors 7 and 9.
Baumann CL,
Aspalter IM,
Sharif O,
Pichlmair A,
Bluml S,
Grebien F,
Bruckner M,
Pasierbek P,
Aumayr K,
Planyavsky M,
Bennett KL,
Colinge J,
Knapp S,
Superti-Furga G.
J Exp Med. 2010 Nov 22;207(12):2689-701. Epub 2010 Nov 15.
2010
A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain.
Wojcik J,
Hantschel O,
Grebien F,
Kaupe I,
Bennett KL,
Barkinge J,
Jones RB,
Koide A,
Superti-Furga G,
Koide S.
Nat Struct Mol Biol. 2010 Apr;17(4):519-27. Epub 2010 Mar 28.
2010
BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib.
Sherbenou DW,
Hantschel O,
Kaupe I,
Willis S,
Bumm T,
Turaga LP,
Lange T,
Dao KH,
Press RD,
Druker BJ,
Superti-Furga G,
Deininger MW.
Blood. 2010 Oct 28;116(17):3278-85. Epub 2010 Jun 2.
2010
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.
Li J,
Rix U,
Fang B,
Bai Y,
Edwards A,
Colinge J,
Bennett KL,
Gao J,
Song L,
Eschrich S,
Superti-Furga G,
Koomen J,
Haura EB.
Nat Chem Biol. 2010 Apr;6(4):291-9. Epub 2010 Feb 28.
2010
Peroxisomes are signaling platforms for antiviral innate immunity.
Dixit E,
Boulant S,
Zhang Y,
Lee AS,
Odendall C,
Shum B,
Hacohen N,
Chen ZJ,
Whelan SP,
Fransen M,
Nibert ML,
Superti-Furga G,
Kagan JC.
Cell. 2010 May 14;141(4): 668-81. Epub 2010 May 6.
2010
Anti-inflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis.
Bluml S,
Binder NB,
Niederreiter B,
Polzer K,
Hayer S,
Tauber S,
Schett G,
Scheinecker C,
Kollias G,
Selzer E,
Bilban M,
Smolen JS,
Superti-Furga G,
Redlich K.
Arthritis Rheum. 2010 Jun;62(6):1608-19.
2010
Novel global network scores to analyze kinase inhibitor profiles.
Colinge J,
Rix U,
Superti-Furga G.
2010 Sep 9, ORSC & APORC, 305-313. Lecture Notes;
2009
The structure of the leukemia drug imatinib bound to human quinine reductase 2 (NQO2).
Winger JA,
Hantschel O,
Superti-Furga G,
Kuriyan J.
BMC Struct Biol, 2009 Feb;9:7.
2009
A biomedical adventurers’ guide to navigating between careers in academia and industry.
Superti-Furga G.
Nat Rev Mol Cell Biol, 2009 Dec;10(12):884-7.
